AstraZeneca to present pancreatic microislet data at EASD Annual Meeting
The 51st annual European Association for the Study of Diabetes (EASD) meeting will take place in Stockholm, Sweden September 14-18. It is the largest international scientific meeting on diabetes and its complications. One of the more than 1200 abstracts being presented this year will feature work performed by AstraZeneca's Dr. Eva-Marie Andersson and colleagues using InSphero 3D InSight™ Pancreatic Microislets. You can view the abstract entitled "Human pancreatic microislets as a standardised model for glucose stimulated insulin and glucagon secretion" on the EASD virtual meeting website.
Learn more about our long-lived, standardized 3D islet model system for diabetes and metabolism research by visiting the product page, or viewing our on demand webinar: 3D InSight™ Human Pancreatic Microislets and the Combined Power of HTRF® Technology.